Form 4 for EW Edwards Lifesciences
Accepted 2025-11-10 00:00:00 ET · period of report 2025-11-10 · accession 0001225208-25-009067 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-11-10 | 2025-11-10 | EW | Ullem Scott B. | CFO, CVP | M - OptEx | $59.26 | +13.0K | 52.9K | +33% | +$770.4K |
| DM | 2025-11-10 | 2025-11-10 | EW | Ullem Scott B. | CFO, CVP | S - Sale+OE | $83.08 | -13.0K | 39.9K | -25% | -$1.08M |
| D | 2025-11-10 | 2025-11-10 | EW | Ullem Scott B. | CFO, CVP | M - OptEx | $0.00 | -13.0K | 46.7K | -22% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-10 | M | A | 13,000 | $59.26 | 52,898 | D | — | — | |
| 2 | Common | Common Stock | 2025-11-10 | S | D | 2,974 | $83.30 | 49,924 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $83.270 to $83.415. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, uponrequest by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. |
| 3 | Common | Common Stock | 2025-11-10 | S | D | 10,026 | $83.02 | 39,898 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $82.270 to $83.260. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, uponrequest by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. |
| 4 | Derivative | Employee Stock Option (Right to Acquire) | 2025-11-10 | M | D | 13,000 | $0.00 | 46,700 | D | $59.26 · 2020-05-08 to 2026-05-07 | 13,000 Common Stock |